about
Benralizumab for the treatment of asthma.Bronchial thermoplasty: implementing best practice in the era of cost containment.First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated.Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestine.Anti-inflammatory potential of a heat-killed Lactobacillus strain isolated from Kimchi on house dust mite-induced atopic dermatitis in NC/Nga mice.Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid.The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies.Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.Benralizumab in the treatment of severe asthma: design, development and potential place in therapy.
P2860
Q38853525-6AE3F696-5CAB-49AA-B98B-27C20873FFAAQ41185749-6D5BC13D-8C15-458A-BEC3-3CA64A7CB1A1Q46090169-67596B8A-DA1F-4A90-9296-F45699CBEB52Q46119974-2204FC5D-2022-41FA-9470-EDE48FBBE527Q47555559-421BB9C3-CFF5-4F22-B6A3-2FF06F6DB568Q48108959-0ADB159F-A8AE-4090-B257-235A37EBB5BCQ48249791-86187748-2AE4-4855-A540-1ABDC69A2257Q50285487-E6C3F787-FAC8-4FB1-A739-42905844643FQ51345374-C0B2ADD5-EEF4-40C6-BA82-647D8A54EA12Q55003087-C90A6D1F-0D2E-43EE-B446-7A94CCB698C0Q55004171-FEE523AD-85F2-4A90-82B9-42184981E069
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Benralizumab: a unique IL-5 inhibitor for severe asthma
@ast
Benralizumab: a unique IL-5 inhibitor for severe asthma
@en
Benralizumab: a unique IL-5 inhibitor for severe asthma
@nl
type
label
Benralizumab: a unique IL-5 inhibitor for severe asthma
@ast
Benralizumab: a unique IL-5 inhibitor for severe asthma
@en
Benralizumab: a unique IL-5 inhibitor for severe asthma
@nl
prefLabel
Benralizumab: a unique IL-5 inhibitor for severe asthma
@ast
Benralizumab: a unique IL-5 inhibitor for severe asthma
@en
Benralizumab: a unique IL-5 inhibitor for severe asthma
@nl
P2093
P2860
P3181
P356
P1476
Benralizumab: a unique IL-5 inhibitor for severe asthma
@en
P2093
Dorottya Godor
Jennifer M Bratt
Laren D Tan
Nicholas J Kenyon
Samuel Louie
P2860
P3181
P356
10.2147/JAA.S78049
P407
P577
2016-01-01T00:00:00Z